210 related articles for article (PubMed ID: 35573572)
1. Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients.
Shouqair TM; Rabbani SA; Sridhar SB; Kurian MT
Cureus; 2022 Apr; 14(4):e24019. PubMed ID: 35573572
[TBL] [Abstract][Full Text] [Related]
2. Clinical Pertinence and Determinants of Potential Drug-Drug Interactions in Chronic Kidney Disease Patients: A Cross-sectional Study.
Khanna J; Kumar S; Mehta S; Chaudhary J; Jain A
J Pharm Technol; 2024 Jun; 40(3):142-151. PubMed ID: 38784027
[No Abstract] [Full Text] [Related]
3. Patterns of drug use and polypharmacy burden in chronic kidney disease patients: An experience from a secondary care hospital in United Arab Emirates.
Shouqair TM; Rabbani SA; Kurian MT
Int J Clin Pharmacol Ther; 2021 Jul; 59(7):519-529. PubMed ID: 33835017
[TBL] [Abstract][Full Text] [Related]
4. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Potential Drug-Drug Interaction Risk among Chronic Kidney Disease Patients in a Spanish Hospital.
Santos-Díaz G; Pérez-Pico AM; Suárez-Santisteban MÁ; García-Bernalt V; Mayordomo R; Dorado P
Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32751436
[TBL] [Abstract][Full Text] [Related]
6. Assessment of prescribed medications and pattern of distribution for potential drug-drug interactions among chronic kidney disease patients attending the Nephrology Clinic of Lagos University Teaching Hospital in Sub-Saharan West Africa.
Fasipe OJ; Akhideno PE; Nwaiwu O; Adelosoye AA
Clin Pharmacol; 2017; 9():125-132. PubMed ID: 29123429
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug reactions and correlations with drug-drug interactions: A retrospective study of reports from 2011 to 2020.
Jiang H; Lin Y; Ren W; Fang Z; Liu Y; Tan X; Lv X; Zhang N
Front Pharmacol; 2022; 13():923939. PubMed ID: 36133826
[No Abstract] [Full Text] [Related]
8. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
[TBL] [Abstract][Full Text] [Related]
9. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria.
Noor S; Ismail M; Khadim F
Malar J; 2020 Aug; 19(1):316. PubMed ID: 32867788
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO
Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey.
Igho-Osagie E; Brzozowski K; Jin H; Brown J; Williams MG; Puenpatom A
Clin Ther; 2023 May; 45(5):390-399.e4. PubMed ID: 37032225
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of potential drug-drug interactions in a public and private hospital among chronic kidney disease patients in Khyber Pakhtunkhwa: A retrospective cross-sectional study.
Zafar R; Rehman IU; Shah Y; Ming LC; Goh HP; Goh KW
PLoS One; 2023; 18(9):e0291417. PubMed ID: 37773947
[TBL] [Abstract][Full Text] [Related]
13. Assessment of drug interactions and their associated factors among patients with cardiovascular diseases: a cross-sectional study from the occupied Palestinian territory.
Al-Jabi SW; Aldabe L; Alhaj-Asaad L; Thaher M; Zyoud SH; Sweileh WM
Lancet; 2021 Jul; 398 Suppl 1():S8. PubMed ID: 34227990
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan.
Nusair MB; Al-Azzam SI; Arabyat RM; Amawi HA; Alzoubi KH; Rabah AA
Saudi Pharm J; 2020 Feb; 28(2):155-160. PubMed ID: 32042253
[TBL] [Abstract][Full Text] [Related]
15. Survivability of hospitalized chronic kidney disease (CKD) patients with moderate to severe estimated glomerular filtration rate (eGFR) after experiencing adverse drug reactions (ADRs) in a public healthcare center: a retrospective 3 year study.
Danial M; Hassali MA; Ong LM; Khan AH
BMC Pharmacol Toxicol; 2018 Aug; 19(1):52. PubMed ID: 30157959
[TBL] [Abstract][Full Text] [Related]
16. Potential drug-drug interactions with phentermine among long-term phentermine consumers: A retrospective analysis.
Fourie A; Julyan M; Mostert L; Du Plessis JM
S Afr Med J; 2023 Aug; 113(8):63-68. PubMed ID: 37882119
[TBL] [Abstract][Full Text] [Related]
17. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of potential drug-drug interactions in older adults with psychiatric disorders: a retrospective study.
Liu Y; Yang M; Ding Y; Wang H; Zhang H; Wang D; Zhuang T; Ji M; Cui Y; Wang H
BMC Psychiatry; 2022 Aug; 22(1):563. PubMed ID: 35996119
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Potential Drug-Drug Interactions in Hospitalized Cardiac Patients of a Secondary Care Hospital in the United Arab Emirates.
Khan MZ; Sridhar SB; Gupta PK
J Res Pharm Pract; 2019; 8(1):20-24. PubMed ID: 30911559
[TBL] [Abstract][Full Text] [Related]
20. Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients.
Murtaza G; Khan MY; Azhar S; Khan SA; Khan TM
Saudi Pharm J; 2016 Mar; 24(2):220-5. PubMed ID: 27013915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
